Under-Registration of Gestational Trophoblastic Disease in the Swedish Cancer Registry

Autor: Flam, F., Rutqvist, L. E.

Publikováno v: European Journal of Epidemiology, 1992 Sep 01. 8(5), 683-686.

Externí odkaz: https://www.jstor.org/stable/3521099

Endocrine treatment options for advanced breast cancer – the role of fulvestrant

Autor: Robertson, J.F.R. ^⁎, Come, S.E., Jones, S.E., Beex, L., Kaufmann, M., Makris, A., Nortier, J.W.R., Possinger, K., Rutqvist, L.-E.

Publikováno v: In European Journal of Cancer 2005 41(3):346-356

Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials

Autor: Klijn, J. G. M., Blamey, R. W., Boccardo, F., Tominaga, T., Duchateau, L., Sylvester, R., Beex, L. V. A. M., Mauriac, L., Zijl, J. A., Veyret, C., Wildiers, J., Jassem, J., Piccart, M., Burghouts, J., Becqaert, D., Seynaeve, C., Mignolet, F., Namer, M., Julien, J. P., Garcia Conde, J., Dunser, M., Margreiter, R., Tjabbes, T., Roozendaal, K. J., Velden, P. C., Nortier, J. W. R., Blamey, R., Howell, A., Forbes, J., Kaufmann, M., Nordenskjold, B., Kvinnsland, S., Wilson, R. G., Jonat, W., Kleeberg, U. R., Eiermann, W., Hilfrich, J., Weitzel, H. K., Glas, U., Rutqvist, L. E., Rudenstam, C., Sander, S., Ryden, S., Honsson, P., Lonning, P. E., Loven, L., Russell, I. S., Olweny, C., Byrne, J. J., Snyder, R. D., Coates, A. S., Lowenthal, R. M., Jeal, P. N., Dalley, D. N., Janicke, F., Kleine, W., Michel, R. Th, Canobbio, L., Amoroso, D., Rubagotti, A., Bumma, C., D Aprile, M., Matteis, A., Di Carlo, A., Francini, G., Petrioli, R., Folco, U., Calligioni, E., Gallotti, P., Lopez, M., Mesiti, M., Pacini, P., Sassi, M., Sismondi, P., Paolo Zola, Ogita, M., Okazaki, M., Watanabe, T., Satomi, T., Hatazawa, C., Okuyama, N., Koyama, T., Kobayashi, M., Shimizu, T., Tabei, T., Sano, M., Makino, H., Ando, J., Kimura, M., Takeuchi, T., Aoyama, H., Koyama, H., Shin, E., Chou, G.

Publikováno v: Journal of Clinical Oncology, 19(2), 343-353. American Society of Clinical Oncology
Scopus-Elsevier

PURPOSE: The logic behind the application of luteinizing hormone-releasing hormone (LHRH) agonists in combination with tamoxifen in premenopausal women is that LHRH agonists on the one hand suppress the tamoxifen-induced stimulation of the pituitary-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca8a0d7f99f4c67a0e9b933f779e688
https://doi.org/10.1200/jco.2001.19.2.343

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of a surgical training programme on rectal cancer outcomes in Stockholm.

Autor: Martling, A., Holm, T., Rutqvist, L. E., Johansson, H., Moran, B. J., Heald, R. J., Cedermark, B.

Publikováno v: British Journal of Surgery; Feb2005, Vol. 92 Issue 2, p225-229, 5p, 2 Diagrams, 2 Charts